Hadassah rolls out outpatient dish infusion to reduce COVID

In an effort to reduce the number of people becoming hospital patients, the Hadassah University Medical Center is offering infusion of coronavirus-infected people to people in the coronavirus. antigens, including viruses, became known last year when former US President Donald Trump received them immediately when he was diagnosed with COVID-19. Trump received Regeneron’s antibody cocktail, which was approved by the FDA in November. He regarded the treatment as a ‘cure’. ” I walked in. I do not feel well. “A short 24 hours later, I felt good,” Trump said in a video he posted on Oct. 7. “I want everyone to get the same treatment as your president, because I feel great.” Hadassah concedes a similar cocktail, Bamlanivimab, developed by US company Eli Lilly, which was also approved by the FDA last November. Bamlanivimab specifically targets the spike protein of SARS-CoV-2 and is designed to prevent the attachment of the virus and access to the cells of a person. The Hadassah program is aimed at newly diagnosed patients who are at high risk of developing a severe case of COVID, such as those who are immunosuppressant, receiving chemotherapy or dialysis, or have had an organ transplant or lung disease. It is also available to any coronavirus-positive person over 65 years of age.

“It is extremely important to let people know that they can change the natural course of this disease,” Zeev Rotstein, director general of Hadassah, told The Jerusalem Post. “Even before they start having symptoms, they have to come. We do not want to lose one day. “Patients must arrive at Hadassah by ambulance to ensure that they do not infect anyone else on their way. The treatment lasts about three hours, including observation. Then they went back to their homes. So far, about a dozen patients have used the program, which was launched last week and is run in collaboration with the health funds and the Ministry of Health, Rotstein said. By infusion. Hadassah is the first Israeli hospital to offer such an outpatient program. Despite the high level of vaccination in Israel, there are still many new cases per day, Rotstein said: “We can save lives with this.”